US Tecfidera Sales Could Plunge By $2.8bn In 2021

Market Reacts To Mylan ‘At-Risk’ Launch

 
• By Dean Rudge
Dollars_Pills
Tecfidera revenues will greatly diminish if Mylan and other generics flood the market • Source: Shutterstock

More from Earnings

More from Business